Evidence map›Paper›PMID 18652554›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2008

Tuberculosis in poorly controlled type 2 diabetes: altered cytokine expression in peripheral white blood cells.

Blanca I Restrepo, Susan P Fisher-Hoch, Paula A Pino, Adrian Salinas, Mohammad H Rahbar, Francisco Mora, Nicolas Cortes-Penfield, Joseph B McCormick

Abstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed, 7 pooled it
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 7 syntheses or guidelines pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Article
  10. Molecular Epidemiology ofMicroorganisms · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Host Risk Factors for Tuberculosis.Infectious disorders drug targets · 2025
    Review
  18. Review
  19. Article
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Blanca I RestrepoDivision of Epidemiology, University of Texas Health Science Center at Houston, School of Public Health, University of Texas at Brownsville, 80 Fort Brown, SPH Bldg., Brownsville, TX 78520, USA. blanca.i.restrepo@utb.edu
Susan P Fisher-Hoch
Paula A Pino
Adrian Salinas
Mohammad H Rahbar
Francisco Mora
Nicolas Cortes-Penfield
Joseph B McCormick
The University of Texas Health Science Center at Houston · USSecretaria de Salud · HNThe University of Texas at Austin · US

Funding

TU SALUD SI CUENTA: A COMMUNITY BASED MEDIA INTERVENTION FOR MEXICAN AMERICANP20MD000170 · NIMHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI RESTREPO, BALANCA · 2003 to 2012
$13.1M
Altered immune-endocrine axis in type 2 diabetes and tuberculosis riskR01AI116039 · NIAID · STELLENBOSCH UNIVERSITY · PI KLEYNHANS, LEANIE, RESTREPO, BLANCA I · 2015 to 2019
$1.7M
Rapid characterization of mycobacteria and drug resistance in paucibacillary TBR21AI064297 · NIAID · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI RESTREPO, BLANCA I · 2006 to 2007
$403k
NCRR NIH HHS 1U54RR023417-01NIAID NIH HHS R01 AI116039NIAID NIH HHS R21 AI064297NIMHD NIH HHS P20 MD000170NIMHD NIH HHS P20 MD000170-04
6 · The paper itself

Abstract

backgroundAlthough the biological basis for the increased susceptibility of diabetic patients to tuberculosis remains unclear, the world is undergoing a type 2 diabetes pandemic. We hypothesize that chronic hyperglycemia leads to immunocompromise that facilitates progression to active tuberculosis. To assess this possibility, we determined whether patients with tuberculosis and diabetes (particularly those with chronic hyperglycemia), compared with patients with tuberculosis who did not have diabetes, presented altered cytokine responses to a mycobacterial antigen.

methodsSamples of whole blood from patients with tuberculosis and diabetes and from patients with tuberculosis who did not have diabetes was stimulated in vitro with purified protein derivative from Mycobacterium tuberculosis. We then determined whether there was an association between the levels of innate and adaptive cytokines secreted in response to the antigen and diabetes status, or diabetes with chronic hyperglycemia (measured by glycosylated hemoglobin level), after controlling for possible confounders.

resultsInnate and type 1 cytokine responses were significantly higher in patients with tuberculosis who had diabetes than in nondiabetic control subjects. The effect was consistently and significantly more marked in diabetic patients with chronic hyperglycemia.

conclusionsThese data provide preliminary evidence that type 2 diabetes, especially type 2 diabetes involving chronic hyperglycemia, is associated with an altered immune response to M. tuberculosis. More-detailed knowledge of the underlying mechanisms should focus on the effect of chronic hyperglycemia on the immune response to help in understanding the enhanced susceptibility of diabetic patients to tuberculosis.

Indexed as

AdultAgedCells, CulturedCytokinesDiabetes Mellitus, Type 2FemaleHumansLeukocytesMaleMiddle AgedMycobacterium tuberculosisTuberculinTuberculosisYoung AdultCytokinesTuberculin

Identifiers

PMID18652554
PMCPMC2900313
OpenAlexW2011321825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.